Apollo Healthcare Corp
TSX:AHC
Intrinsic Value
Apollo Healthcare Corp. engages in manufacturing and developing private label personal care products and retailer-branded products for North American retailers. [ Read More ]
There is not enough data to reliably calculate the intrinsic value of AHC.
Fundamental Analysis
Balance Sheet Decomposition
Apollo Healthcare Corp
Current Assets | 86.7m |
Cash & Short-Term Investments | 35.2m |
Receivables | 19.3m |
Other Current Assets | 32.2m |
Non-Current Assets | 61.5m |
PP&E | 45m |
Intangibles | 15.7m |
Other Non-Current Assets | 876k |
Current Liabilities | 19.9m |
Other Current Liabilities | 19.9m |
Non-Current Liabilities | 12.3m |
Long-Term Debt | 12.3m |
Earnings Waterfall
Apollo Healthcare Corp
Revenue
|
202.6m
CAD
|
Cost of Revenue
|
-118.8m
CAD
|
Gross Profit
|
83.9m
CAD
|
Operating Expenses
|
-37m
CAD
|
Operating Income
|
46.8m
CAD
|
Other Expenses
|
-4.6m
CAD
|
Net Income
|
42.3m
CAD
|
Free Cash Flow Analysis
Apollo Healthcare Corp
AHC Profitability Score
Profitability Due Diligence
Apollo Healthcare Corp's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
Score
Apollo Healthcare Corp's profitability score is 44/100. The higher the profitability score, the more profitable the company is.
AHC Solvency Score
Solvency Due Diligence
Apollo Healthcare Corp's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Score
Apollo Healthcare Corp's solvency score is 76/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
AHC Price Targets Summary
Apollo Healthcare Corp
Shareholder Return
AHC Price
Apollo Healthcare Corp
Average Annual Return | 445.33% |
Standard Deviation of Annual Returns | 657.15% |
Max Drawdown | -72% |
Market Capitalization | 327.3m CAD |
Shares Outstanding | 72 743 990 |
Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
Apollo Healthcare Corp. engages in manufacturing and developing private label personal care products and retailer-branded products for North American retailers. The company is headquartered in Toronto, Ontario and currently employs 500 full-time employees. The company went IPO on 2015-09-08. The firm is engaged in developing and manufacturing retailer branded and private label products for North American retailers. The firm operates through private label consumer staples business segment. The Company’s products are sold in stores across North America and serves North American grocery, drug, and mass merchandise retailers, as well as wholesale clubs. Along with private label, the Company also manufactures products on a contract basis for its clients.